Japanese pharmaceutical giant Chugai and Boston-based digital therapeutics company Biofourmis announced that they have partnered to develop a digital solution for the objective assessment of pain associated with endometriosis.
Affecting one out of 10 women in their 20s to 40s, endometriosis is the repeated proliferation and shedding of endometrial tissue outside the uterus, accompanied by...
